Skip to main content

Table 4 KEGG Pathway Enrichment Analysis for differential genes in MDS vs control muscle

From: Transcriptomic profiling of TK2 deficient human skeletal muscle suggests a role for the p53 signalling pathway and identifies growth and differentiation factor-15 as a potential novel biomarker for mitochondrial myopathies

KEGG Pathway

FDR (%)

Over-expressed

 

Intestinal immune network for IgA production

0.03

Systemic lupus erythematosus

0.05

Viral myocarditis

0.09

Type I diabetes mellitus

0.10

Allograft rejection

0.33

Graft-versus-host disease

0.52

Cell adhesion molecules (CAMs)

0.67

Asthma

0.92

p53 signaling pathway

2.05

Autoimmune thyroid disease

2.20

PPAR signaling pathway

2.24

Glycine, serine and threonine metabolism

8.98

Under-expressed

 

Cardiac muscle contraction

1.16E-04

Glycolysis/gluconeogenesis

0.05

Fructose and mannose metabolism

0.09

Hypertrophic cardiomyopathy (HCM)

0.61

Dilated cardiomyopathy

1

Calcium signaling pathway

1.9

Starch and sucrose metabolism

2.4

Arrhythmogenic right ventricular cardiomyopathy (ARVC)

7.2

  1. MDS: mitochondrial DNA depletion syndrome group. FDR: false discovery rate.